Silexion Therapeutics (SLXN) Common Equity (2023 - 2026)
Silexion Therapeutics (SLXN) recorded Common Equity of $44,000 in Q2 2026, down 63.3% from $120,000 a year earlier and down 84.9% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Silexion Therapeutics reported Common Equity of $2.6 million.
- Across earlier years, Common Equity came in at -$3.99 million in FY2024 and -$15.48 million in FY2023.
- The Q2 2026 figure is the lowest quarterly Common Equity since Q4 2024.
- On a year-over-year basis, Common Equity rose in 1 of the last four quarters, with an average decline of 28.3%.
- Per Business Quant, the preceding three quarters came in at $291,000 (Q1 2026), $2.6 million (Q4 2025) and $6.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Silexion Therapeutics | 113,481.98 | -19.76 Mn | - | 44,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44,000.00 |
| Mar 31, 2026 | 291,000.00 |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 6.98 Mn |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | -3.99 Mn |
| Sep 30, 2024 | -4.58 Mn |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | -15.48 Mn |
| Sep 30, 2023 | -4.65 Mn |
| Jun 30, 2023 | 5.42 Mn |
API Access
Silexion Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();